ArticleClinical and translational medicine2022

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma.

Guangtong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.